Whitehawk Therapeutics (WHWK) Receivables - Net (2016 - 2024)

Whitehawk Therapeutics (WHWK) has 6 years of Receivables - Net data on file, last reported at $5.9 million in Q4 2024.

• Receivables - Net for Q4 2024 came in at $5.9 million, up 7.56% year-over-year; the trailing twelve-month figure through Dec 2024 was $5.9 million (up 7.56% YoY), and the FY2024 annual result was $5.9 million, up 7.56% from the prior year.
• Receivables - Net slipped to $5.9 million in Q4 2024 per WHWK's latest filing, from $6.5 million in the prior quarter.
• Over five years, Receivables - Net peaked at $14.1 million in Q4 2020 and troughed at $1.9 million in Q4 2022.
• A 4-year average of $5.1 million and a median of $5.5 million in 2023 frame the typical range for Receivables - Net.
• The sharpest annual moves came in 2023 and 2024: Receivables - Net soared 194.74% in 2023, then fell 11.36% in 2024.
• A 4-year view of Receivables - Net shows it stood at $14.1 million in 2020, then plunged by 86.84% to $1.9 million in 2022, then soared by 194.74% to $5.5 million in 2023, then gained by 7.56% to $5.9 million in 2024.
• Business Quant data shows WHWK's Receivables - Net at $5.9 million in Q4 2024, $6.5 million in Q3 2024, and $5.9 million in Q2 2024.